Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lymphedema: which drug therapy?].

V Boursier1

  • 1Unité de lymphologie, hôpital Cognacq-Jay, site Broussais, 102, rue Didot, 75014 Paris, France. virginie.boursier@voila.fr

La Revue De Medecine Interne
|August 7, 2002
PubMed
Summary

Lymphedema treatment primarily involves complex decongestive physiotherapy. While drug therapies like diuretics and benzopyrones show limited efficacy, research into new treatments for lymphedema is ongoing, with prevention crucial post-breast cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Improving blood pressure control after a stroke: The place of therapeutic education in the acute phase].

Journal de medecine vasculaire·2019
Same author

Compression therapy in 100 consecutive patients with venous leg ulcers.

Journal des maladies vasculaires·2013
Same author

[Metabolic syndrome].

Journal des maladies vasculaires·2006
Same author

[Interest of cutaneous resection after reduction of volume by decongestive physiotherapy in huge primary lymphedema of lower limb].

Journal des maladies vasculaires·2005
Same author

[Comparative analysis of lymphoscintigraphy between lipedema and lower limb lymphedema].

Journal des maladies vasculaires·2005
Same author

[Limb lymphedema as a first manifestation of primary intestinal lymphangiectasia (Waldmann's disease)].

Journal des maladies vasculaires·2004

Area of Science:

  • Medical Science
  • Oncology
  • Physiotherapy

Context:

  • Lymphedema, a chronic condition often resulting from cancer treatment, significantly impacts patient quality of life.
  • Current standard treatment relies heavily on complex decongestive physiotherapy.
  • The search for effective pharmacological interventions to complement physiotherapy is a persistent challenge.

Purpose:

  • To review existing and emerging drug therapies for lymphedema management.
  • To evaluate the efficacy and limitations of pharmacological approaches.
  • To highlight the need for rigorous clinical trials in lymphedema drug development.

Summary:

  • Complex decongestive physiotherapy is the cornerstone of lymphedema treatment.
  • Pharmacological agents, including diuretics and benzopyrones, have demonstrated limited and conflicting results.
  • New lymphedema treatments require validation through randomized controlled studies.

Impact:

  • Improved understanding of current therapeutic options for lymphedema.
  • Identification of research gaps in pharmacological lymphedema treatment.
  • Emphasis on the critical role of lymphedema prevention, particularly after breast cancer surgery.

Related Experiment Videos